These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12776722)

  • 1. Low-molecular-weight heparins and heparinoids.
    Williamson OD; Street AM
    Med J Aust; 2003 Apr; 178(8):414; author reply 414-5. PubMed ID: 12776722
    [No Abstract]   [Full Text] [Related]  

  • 2. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.
    Gerhardt A; Zotz RB; Stockschlaeder M; Scharf RE
    Thromb Haemost; 2007 Mar; 97(3):496-7. PubMed ID: 17334521
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.
    Ludwig RJ; Beier C; Lindhoff-Last E; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2003 Sep; 49(3):158-9. PubMed ID: 14678213
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance of Fondaparinux in Immediate-type Hypersensitivity to Heparins.
    Trog LM; Kahle B; Schindewolf M; Jappe U; Ludwig RJ
    Am J Med; 2015 Nov; 128(11):e21-2. PubMed ID: 26169891
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fondaparinux for thrombosis prevention after orthopaedic surgery: a revolution?].
    Monreal M
    Med Clin (Barc); 2003 May; 120(20):775-6. PubMed ID: 12797930
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG
    Curr Opin Pulm Med; 2002 Sep; 8(5):398-404. PubMed ID: 12172443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism.
    Robinson DM; Wellington K
    Am J Cardiovasc Drugs; 2005; 5(5):335-46. PubMed ID: 16156690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New anticoagulants in the treatment of venous thrombo-embolic disease].
    Bura-Riviere A; Fiessinger JN
    Rev Med Interne; 2003 Nov; 24(11):738-44. PubMed ID: 14604751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondaparinux (Arixtra): a new anticoagulant.
    Giangrande PL
    Int J Clin Pract; 2002 Oct; 56(8):615-7. PubMed ID: 12425373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial management of deep venous thrombosis in the outpatient setting.
    Groce JB
    Am J Health Syst Pharm; 2008 May; 65(9):866-74. PubMed ID: 18436734
    [No Abstract]   [Full Text] [Related]  

  • 11. Current and emerging options in the management of venous thromboembolism.
    Jaffer AK; Brotman DJ; Michota F
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S14-23. PubMed ID: 15853175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of fondaparinux for the prevention and treatment of venous thromboembolism.
    Turpie AG
    Expert Opin Drug Saf; 2005 Jul; 4(4):707-21. PubMed ID: 16011449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern anticoagulation. Problems of the proven, hope for the new].
    Bauersachs R; Breddin HK
    Internist (Berl); 2004 Jun; 45(6):717-26. PubMed ID: 15107981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances and contemporary issues in prophylaxis for deep vein thrombosis.
    Hirsh J
    Chest; 2003 Dec; 124(6 Suppl):347S-348S. PubMed ID: 14668416
    [No Abstract]   [Full Text] [Related]  

  • 15. The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
    Turpie AG
    Int J Clin Pract; 2004 May; 58(5):483-93. PubMed ID: 15206506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anticoagulants for the prevention and treatment of venous thromboembolism.
    McRae SJ; Ginsberg JS
    Vasc Health Risk Manag; 2005; 1(1):41-53. PubMed ID: 17319097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery.
    Bergqvist D
    Vasc Health Risk Manag; 2006; 2(4):365-70. PubMed ID: 17323590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deep vein thrombosis: new drugs and future therapeutic perspectives].
    García Vidal R; Berga Fauria C; Paredero VM
    Rev Clin Esp; 2006 Jun; 206(6):281-3. PubMed ID: 16762292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory venous thrombus propagation in the setting of therapeutic anticoagulation.
    Traeger ZT; Rizzo JR; Rashbaum I
    Am J Phys Med Rehabil; 2011 Oct; 90(10):873-4. PubMed ID: 21862910
    [No Abstract]   [Full Text] [Related]  

  • 20. Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.
    Beyer-Westendorf J; Werth S; Folprecht G; Weiss N
    Br J Clin Pharmacol; 2011 Oct; 72(4):715-6. PubMed ID: 21392076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.